Literature DB >> 12379360

Structural diversity of antibody catalysts.

Béatrice Golinelli-Pimpaneau1.   

Abstract

The structural diversity of the immune response may be considerably restricted by the structure of the hapten used to elicit catalytic antibodies. The ligand-binding mode and the shapes of the binding pockets of hydrolytic antibodies induced to different transition-state analogs that contain an unsubstituted arylphosphonate group are very similar. Moreover, antibodies elicited against a single transition state analog evolve from a single germline gene or different precursors, depending on the nature of the hapten. Germline antibodies seem to adopt multiple conformations with antigen binding, together with somatic mutation stabilizing the conformation with optimum complementarity to antigen.

Mesh:

Substances:

Year:  2002        PMID: 12379360     DOI: 10.1016/s0022-1759(02)00240-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.

Authors:  Sanjiv Sonkaria; Guillaume Boucher; José Flórez-Olvarez; Bilal Said; Syeed Hussain; Elizabeth L Ostler; Sheraz Gul; Emrys W Thomas; Marina Resmini; Gerard Gallacher; Keith Brocklehurst
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

2.  Identification and characterization of single chain anti-cocaine catalytic antibodies.

Authors:  Kathleen M McKenzie; Jenny M Mee; Claude J Rogers; Mark S Hixon; Gunnar F Kaufmann; Kim D Janda
Journal:  J Mol Biol       Date:  2006-11-03       Impact factor: 5.469

3.  Crystal structure of two anti-porphyrin antibodies with peroxidase activity.

Authors:  Victor Muñoz Robles; Jean-Didier Maréchal; Amel Bahloul; Marie-Agnès Sari; Jean-Pierre Mahy; Béatrice Golinelli-Pimpaneau
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.